DIFFERENTIAL-EFFECTS OF CONTINUOUS ADMINISTRATION FOR 1 YEAR OF HALOPERIDOL OR SULPIRIDE ON STRIATAL DOPAMINE FUNCTION IN THE RAT

被引:58
作者
RUPNIAK, NMJ
MANN, S
HALL, MD
FLEMINGER, S
KILPATRICK, G
JENNER, P
MARSDEN, CD
机构
[1] UNIV LONDON,DEPT NEUROL,MRC,MOVEMENT DISORDERS RES GRP,DENMARK HILL,LONDON SE5 8AF,ENGLAND
[2] KINGS COLL HOSP,SCH MED,LONDON SE5 8AF,ENGLAND
[3] ARC,INST ANIM PHYSIOL,CAMBRIDGE CB2 4AT,ENGLAND
[4] INST PSYCHIAT,PARKINSONS DIS SOC RES CTR,LONDON SE5 8AF,ENGLAND
关键词
D O I
10.1007/BF00431457
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:503 / 511
页数:9
相关论文
共 38 条
[11]   EVIDENCE FOR DOPAMINE RECEPTORS MEDIATING SEDATION IN MOUSE-BRAIN [J].
DICHIARA, G ;
PORCEDDU, ML ;
VARGIU, L ;
ARGIOLAS, A ;
GESSA, GL .
NATURE, 1976, 264 (5586) :564-567
[12]   SUBSTITUTED BENZAMIDES AS CEREBRAL DOPAMINE ANTAGONISTS IN RODENTS [J].
ELLIOTT, PNC ;
JENNER, P ;
HUIZING, G ;
MARSDEN, CD ;
MILLER, R .
NEUROPHARMACOLOGY, 1977, 16 (05) :333-342
[13]   SYNTHESIS OF ACETYLCHOLINE BY TISSUE OF THE CENTRAL NERVOUS SYSTEM [J].
FELDBERG, W .
JOURNAL OF PHYSIOLOGY-LONDON, 1945, 103 (04) :367-402
[14]   CHANGES IN APOMORPHINE-INDUCED STEREOTYPY AS A RESULT OF SUBACUTE NEUROLEPTIC TREATMENT CORRELATES WITH INCREASED D-2 RECEPTORS, BUT NOT WITH INCREASES IN D-1 RECEPTORS [J].
FLEMINGER, S ;
RUPNIAK, NMJ ;
HALL, MD ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) :2921-2927
[15]   POTENT LIPOPHILIC SUBSTITUTED BENZAMIDE DRUGS ARE NOT SELECTIVE D-1 DOPAMINE RECEPTOR ANTAGONISTS IN THE RAT [J].
FLEMINGER, S ;
VANDEWATERBEEMD, H ;
RUPNIAK, NMJ ;
REAVILL, C ;
TESTA, B ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (06) :363-368
[16]  
Fuxe K, 1980, Adv Biochem Psychopharmacol, V24, P193
[17]  
HALL MD, 1981, NEUROSCI LETT S, V7, P363
[18]   IMMUNOHISTOCHEMICAL LOCALIZATION OF CHOLINE-ACETYLTRANSFERASE CONTAINING NEOSTRIATAL NEURONS AND THEIR RELATIONSHIP WITH DOPAMINERGIC SYNAPSES [J].
HATTORI, T ;
SINGH, VK ;
MCGEER, EG ;
MCGEER, PL .
BRAIN RESEARCH, 1976, 102 (01) :164-173
[19]  
HOWELLS RB, 1979, NEUROSCI LETT S, V3, P210
[20]   REPEATED ADMINISTRATION OF SULPIRIDE FOR 3 WEEKS PRODUCES BEHAVIORAL AND BIOCHEMICAL-EVIDENCE FOR CEREBRAL DOPAMINE RECEPTOR SUPER-SENSITIVITY [J].
JENNER, P ;
HALL, MD ;
MURUGAIAH, K ;
RUPNIAK, N ;
THEODOROU, A ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) :325-328